Skip to main content

Roux-en-Y Gastric Bypass Is Associated With Increased Hazard for De Novo Alcohol-related Complications and Liver Disease.

Publication ,  Journal Article
Kim, HP; Jiang, Y; Farrell, TM; Peat, CM; Hayashi, PH; Barritt, AS
Published in: Journal of clinical gastroenterology
February 2022

The goal of this study was to determine if bariatric surgeries are associated with de novo alcohol-related complications.Bariatric surgery is associated with an increased risk of alcohol use disorders. The effect of bariatric surgeries on other alcohol-related outcomes, including liver disease, is understudied.Using the IMS PharMetrics database, we performed a cohort study of adults undergoing bariatric surgery or cholecystectomy, excluding patients with an alcohol-related diagnosis within 1 year before surgery. The primary outcome was any alcohol-related diagnosis after surgery. We fit a multivariable Cox proportional hazards model to determine independent associations between bariatric surgeries [Roux-en-Y gastric bypass (RYGB); adjustable gastric band; sleeve gastrectomy] versus cholecystectomy and the development of de novo alcohol-related outcomes. We further fit complication-specific models for each alcohol-related diagnosis.RYGB was significantly associated with an increased hazard of any de novo alcohol-related diagnosis [adjusted hazard ratio (AHR)=1.51, 95% confidence interval (CI): 1.40-1.62], while adjustable gastric band (AHR=0.55, 95% CI: 0.48-0.63) and sleeve gastrectomy (AHR=0.77, 95% CI: 0.64-0.91) had decreased hazards. RYGB was associated with a 2- to 3-fold higher hazard for alcoholic hepatitis (AHR=1.98, 95% CI: 1.17-3.33), abuse (AHR=2.05, 95% CI: 1.88-2.24), and poisoning (3.14, 95% CI: 1.80-5.49).RYGB was associated with higher hazards of developing de novo alcohol-related hepatitis, abuse, and poisoning compared with a control group. Patients without a history of alcohol use disorder should still be counseled on the increased risk of alcohol use and alcohol-related complications, including alcohol-related liver disease, following RYGB, and should be monitored long term for the development of alcohol-related complications.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Journal of clinical gastroenterology

DOI

EISSN

1539-2031

ISSN

0192-0790

Publication Date

February 2022

Volume

56

Issue

2

Start / End Page

181 / 185

Related Subject Headings

  • Treatment Outcome
  • Retrospective Studies
  • Postoperative Complications
  • Obesity, Morbid
  • Liver Diseases
  • Humans
  • Gastroenterology & Hepatology
  • Gastric Bypass
  • Gastrectomy
  • Cohort Studies
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kim, H. P., Jiang, Y., Farrell, T. M., Peat, C. M., Hayashi, P. H., & Barritt, A. S. (2022). Roux-en-Y Gastric Bypass Is Associated With Increased Hazard for De Novo Alcohol-related Complications and Liver Disease. Journal of Clinical Gastroenterology, 56(2), 181–185. https://doi.org/10.1097/mcg.0000000000001506
Kim, Hannah P., Yue Jiang, Timothy M. Farrell, Christine M. Peat, Paul H. Hayashi, and Alfred Sidney Barritt. “Roux-en-Y Gastric Bypass Is Associated With Increased Hazard for De Novo Alcohol-related Complications and Liver Disease.Journal of Clinical Gastroenterology 56, no. 2 (February 2022): 181–85. https://doi.org/10.1097/mcg.0000000000001506.
Kim HP, Jiang Y, Farrell TM, Peat CM, Hayashi PH, Barritt AS. Roux-en-Y Gastric Bypass Is Associated With Increased Hazard for De Novo Alcohol-related Complications and Liver Disease. Journal of clinical gastroenterology. 2022 Feb;56(2):181–5.
Kim, Hannah P., et al. “Roux-en-Y Gastric Bypass Is Associated With Increased Hazard for De Novo Alcohol-related Complications and Liver Disease.Journal of Clinical Gastroenterology, vol. 56, no. 2, Feb. 2022, pp. 181–85. Epmc, doi:10.1097/mcg.0000000000001506.
Kim HP, Jiang Y, Farrell TM, Peat CM, Hayashi PH, Barritt AS. Roux-en-Y Gastric Bypass Is Associated With Increased Hazard for De Novo Alcohol-related Complications and Liver Disease. Journal of clinical gastroenterology. 2022 Feb;56(2):181–185.

Published In

Journal of clinical gastroenterology

DOI

EISSN

1539-2031

ISSN

0192-0790

Publication Date

February 2022

Volume

56

Issue

2

Start / End Page

181 / 185

Related Subject Headings

  • Treatment Outcome
  • Retrospective Studies
  • Postoperative Complications
  • Obesity, Morbid
  • Liver Diseases
  • Humans
  • Gastroenterology & Hepatology
  • Gastric Bypass
  • Gastrectomy
  • Cohort Studies